￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Oncology

Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Will Giteri (afatinib) be included in the national medical insurance in China in 2021?

2025-10-19 11:44:20

Check Details
Is the targeted drug cabozantinib covered by medical insurance?

2025-10-19 11:44:20

Check Details
China Food and Drug Administration approves erlotinib hydrochloride tablets for third-line treatment of advanced non-small cell lung cancer after failure of previous chemotherapy

2025-10-19 11:44:20

Check Details
Are there alternative drugs after ceritinib resistance?

2025-10-19 11:44:20

Check Details
Efficacy and safety of cabozantinib in the treatment of RET-rearranged lung cancer

2025-10-19 11:44:20

Check Details
How long does it take for patients to develop drug resistance after taking Giterinib (afatinib)?

2025-10-19 11:44:20

Check Details
How much will Seritinib cost after it is included in medical insurance in 2021?

2025-10-19 11:44:20

Check Details
How should patients with lung cancer correctly use the targeted drug cabozantinib?

2025-10-19 11:44:20

Check Details
Jitai Rui’s medical insurance reimbursement ratio in 2021

2025-10-19 11:44:20

Check Details
[What you are concerned about] The price of ceritinib after medical insurance reimbursement this year

2025-10-19 11:44:20

Check Details
The price of Gitairi before it is included in medical insurance

2025-10-19 11:44:20

Check Details
Cabozantinib administration method and dosage in lung cancer

2025-10-19 11:44:20

Check Details
Category
相关知识